The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation
Open accessAbstract
BACKGROUND: The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. We aimed to provide reliable estimates of the associations between age at diagnosis of diabetes and all-cause mortality, cause-specific mortality, and reductions in life expectancy. METHODS: For this observational study, we conducted a combined analysis of individual-participant data from 19 high-income countries using two large-scale data sources: the Emerging Risk Factors Collaboration (96 cohorts, median baseline years 1961-2007, median latest follow-up years 1980-2013) and the UK Biobank (median baseline year 2006, median latest follow-up year 2020). We calculated age-adjusted and sex-adjusted hazard ratios (HRs) for all-cause mortality according to age at diagnosis of diabetes using data from 1 515 718 participants, in whom deaths were recorded during 23·1 million person-years of follow-up. We estimated cumulative survival by applying age-specific HRs to age-specific death rates from 2015 for the USA and the EU. FINDINGS: For participants with diabetes, we observed a linear dose-response association between earlier age at diagnosis and higher risk of all-cause mortality compared with participants without diabetes. HRs were 2·69 (95% CI 2·43-2·97) when diagnosed at 30-39 years, 2·26 (2·08-2·45) at 40-49 years, 1·84 (1·72-1·97) at 50-59 years, 1·57 (1·47-1·67) at 60-69 years, and 1·39 (1·29-1·51) at 70 years and older. HRs per decade of earlier diagnosis were similar for men and women. Using death rates from the USA, a 50-year-old individual with diabetes died on average 14 years earlier when diagnosed aged 30 years, 10 years earlier when diagnosed aged 40 years, or 6 years earlier when diagnosed aged 50 years than an individual without diabetes. Using EU death rates, the corresponding estimates were 13, 9, or 5 years earlier. INTERPRETATION: Every decade of earlier diagnosis of diabetes was associated with about 3-4 years of lower life expectancy, highlighting the need to develop and implement interventions that prevent or delay the onset of diabetes and to intensify the treatment of risk factors among young adults diagnosed with diabetes. FUNDING: British Heart Foundation, Medical Research Council, National Institute for Health and Care Research, and Health Data Research UK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“31 After giving consent, participants provided biological samples and com pleted a touch-screen questionnaire, a computer-assisted interview, and a physical examination (appendix p 26).”
MethodSelf-citationThe Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · cited 1×
“5,32 To calculate age at diagnosis of diabetes, we used information recorded at the baseline enrolment survey in prospective cohort studies, supplemented, when available, by information on new-onset incident type 2 diabetes recorded during follow-up (appendix p 27).”
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · cited 1×
“We ascertained baseline diabetes status on the basis of self-report information, medical records, medication usage, or a combination of these factors (appendix p 4).”
Principles of confounder selection
VanderWeele, T. J. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00494-6 · Cited by 1,535 · cited 1×
“37 We investigated effect modification using tests for interaction for individual characteristics (age, sex, smoking, and history of cardiovascular disease) and by meta-regression of study-specific log HRs (ie, outcome) on study-level characteristics (diabetes diagnosis information available,…”
MethodLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationSattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Self-citationZoungas, S., Arima, H., Gerstein, H. C., Holman, R. R., Woodward, M., Reaven, P., Hayward, R. A., Craven, T., Coleman, R. L., & Chalmers, J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30104-3 · Cited by 529
Research works printed but not linked: 37
- Zhou, 2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8 · DOI · Paper page
- Geiss, 2014, Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012, JAMA, 312, 1218, 10.1001/jama.2014.11494 · DOI · Paper page
- Gregg, 2014, Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study, Lancet Diabetes Endocrinol, 2, 867, 10.1016/S2213-8587(14)70161-5 · DOI · Paper page
- Tomic, 2022, Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study, Lancet Diabetes Endocrinol, 10, 795, 10.1016/S2213-8587(22)00252-2 · DOI
- Pavkov, 2006, Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians, JAMA, 296, 421, 10.1001/jama.296.4.421 · DOI · Paper page
- Barnett, 2010, A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland, Diabet Med, 27, 1124, 10.1111/j.1464-5491.2010.03075.x · DOI
- Gulliford, 2009, Is relative mortality of type 2 diabetes mellitus decreasing?, Am J Epidemiol, 169, 455, 10.1093/aje/kwn342 · DOI
- Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, JAMA, 314, 52, 10.1001/jama.2015.7008 · DOI · Paper page
- Al-Saeed, 2016, An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes, Diabetes Care, 39, 823, 10.2337/dc15-0991 · DOI · Paper page
- Brun, 2000, Diabetes duration and cause-specific mortality in the Verona Diabetes Study, Diabetes Care, 23, 1119, 10.2337/diacare.23.8.1119 · DOI
- Silbernagel, 2012, Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography, Atherosclerosis, 221, 551, 10.1016/j.atherosclerosis.2012.01.011 · DOI
- Herrington, 2018, Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study, Lancet Diabetes Endocrinol, 6, 455, 10.1016/S2213-8587(18)30050-0 · DOI
- Wannamethee, 2011, Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors, Arch Intern Med, 171, 404, 10.1001/archinternmed.2011.2 · DOI · Paper page
- Huo, 2018, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011, Diabetologia, 61, 1055, 10.1007/s00125-018-4544-z · DOI · Paper page
- Færch, 2014, Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002–2010), J Clin Endocrinol Metab, 99, E642, 10.1210/jc.2013-3210 · DOI
- Knuiman, 1992, An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model, Am J Epidemiol, 135, 638, 10.1093/oxfordjournals.aje.a116343 · DOI
- Li, 2012, Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000–2009, J Formos Med Assoc, 111, 645, 10.1016/j.jfma.2012.09.013 · DOI
- Holden, 2013, The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010, Diabetes Obes Metab, 15, 844, 10.1111/dom.12123 · DOI · Paper page
- Nwaneri, 2012, Falling mortality rates in type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study, Postgrad Med J, 88, 679, 10.1136/postgradmedj-2012-130877 · DOI
- Huo, 2016, Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study, Lancet Diabetes Endocrinol, 4, 115, 10.1016/S2213-8587(15)00508-2 · DOI · Paper page
- Alva, 2018, State-level diabetes-attributable mortality and years of life lost in the United States, Ann Epidemiol, 28, 790, 10.1016/j.annepidem.2018.08.015 · DOI
- Tönnies, 2021, Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040, Popul Health Metr, 19, 38, 10.1186/s12963-021-00266-z · DOI
- Koyama, 2022, Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997–2018, PLoS One, 17, 10.1371/journal.pone.0268805 · DOI
- Leung, 2015, Life years lost and lifetime health care expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997–2000, Diabetes Care, 38, 460, 10.2337/dc14-1453 · DOI
- 2007, The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, Eur J Epidemiol, 22, 839, 10.1007/s10654-007-9165-7 · DOI · Paper page
- Pintilie, 2007, Analysing and interpreting competing risk data, Stat Med, 26, 1360, 10.1002/sim.2655 · DOI · Paper page
- Freidlin, 2005, Testing treatment effects in the presence of competing risks, Stat Med, 24, 1703, 10.1002/sim.2054 · DOI
- Tai, 2008, First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?, Stat Med, 27, 922, 10.1002/sim.2944 · DOI
- Thompson, 2010, Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies, Int J Epidemiol, 39, 1345, 10.1093/ije/dyq063 · DOI
- Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Steinarsson, 2018, Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register, Diabetologia, 61, 599, 10.1007/s00125-017-4532-8 · DOI
- Zoungas, 2014, Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes, Diabetologia, 57, 2465, 10.1007/s00125-014-3369-7 · DOI · Paper page
- Porta, 2014, Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence, Diabetes Care, 37, 1668, 10.2337/dc13-2101 · DOI
- Thomas, 2018, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, Lancet Diabetes Endocrinol, 6, 122, 10.1016/S2213-8587(17)30362-5 · DOI · Paper page
- Mansournia, 2022, A practical guide to handling competing events in etiologic time-to-event studies, Glob Epidemiol, 4
- Hernán, 2010, The hazards of hazard ratios, Epidemiology, 21, 13, 10.1097/EDE.0b013e3181c1ea43 · DOI · Paper page
Cited by
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Sattar, N., Presslie, C., Rutter, M. K., & McGuire, D. K. (2024) · Diabetes Care · doi:10.2337/dci23-0041 · Cited by 70
Self-citationKong, S.-Y., & Cho, M.-K. (2024) · Healthcare · doi:10.3390/healthcare12050571 · Cited by 36
Mens, M. M. J., Jopling, E., Hare, M., Drury, S. S., Nelson, C. A., Zeanah, C. H., Fox, N. A., & Slopen, N. (2026) · Development and Psychopathology · doi:10.1017/s0954579426101540 · Cited by 1
Benton, M., Payne, E., Waheed, N., Turner, K., Murphy, H. R., Skouteris, H., Ismail, K., & Silverio, S. A. (2025) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70038
Metadata
- Authors
- Kaptoge, S., Seshasai, S., Sun, L., Walker, M., Bolton, T., Spackman, S., Ataklte, F., Willeit, P., Bell, S., Burgess, S., Pennells, L., Altay, S., Assmann, G., Ben-Shlomo, Y., Best, L., Björkelund, C., Blazer, D., Brenner, H., Brunner, E., Dagenais, G., Cooper, J., Cooper, C., Crespo, C., Cushman, M., D'Agostino, R., Daimon, M., Daniels, L., Danker, R., Davidson, K., de Jongh, R., Donfrancesco, C., Ducimetiere, P., Elders, P., Engström, G., Ford, I., Gallacher, I., Bakker, S., Goldbourt, U., de La Cámara, G., Grimsgaard, S., Gudnason, V, Hansson, P., Imano, H., Jukema, J., Kabrhel, C., Kauhanen, J., Kavousi, M., Kiechl, S., Knuiman, M., Kromhout, D., Krumholz, H., Kuller, L., Laatikainen, T., Lowler, D., Meyer, H., Mukamal, K., Nietert, P., Ninomiya, T., Nitsch, D., Nordestgaard, B., Palmieri, L., Price, J., Ridker, P., Sun, Q., Rosengren, A., Roussel, R., Sakurai, M., Salomaa, V, Schöttker, B., Shaw, J., Strandberg, T., Sundström, J., Tolonen, H., Tverdal, A., Verschuren, W., Völzke, H., Wagenknecht, L., Wallace, R., Wannamethee, S., Wareham, N., Wassertheil-Smoller, S., Yamagishi, K., Yeap, B., Harrison, S., Inouye, M., Griffin, S., Butterworth, A., Wood, A., Thompson, S., Sattar, N., Danesh, J., Di Angelantonio, E., Tipping, R., Russell, S., Johansen, M., Bancks, M., Mongraw-Chaffin, M., Magliano, D., Barr, E., Zimmet, P., Knuiman, M., Whincup, P., Willeit, J., Willeit, P., Leitner, C., Lawlor, D., Ben-Shlomo, Y., Elwood, P., Sutherland, S., Hunt, K., Cushman, M., Selmer, R., Haheim, L., Ariansen, I., Tybjaer-Hansen, A., Frikkle-Schmidt, R., Langsted, A., Donfrancesco, C., Lo Noce, C., Balkau, B., Bonnet, F., Fumeron, F., Pablos, D., Ferro, C., Morales, T., Mclachlan, S., Guralnik, J., Khaw, K., Brenner, H., Holleczek, B., Stocker, H., Nissinen, A., Palmieri, L., Vartiainen, E., Jousilahti, P., Harald, K., Massaro, J., Pencina, M., Lyass, A., Susa, S., Oizumi, T., Kayama, T., Chetrit, A., Roth, J., Orenstein, L., Welin, L., Svärdsudd, K., Lissner, L., Hange, D., Mehlig, K., Salomaa, V, Tilvis, R., Dennison, E., Cooper, C., Westbury, L., Norman, P., Almeida, O., Hankey, G., Hata, J., Shibata, M., Furuta, Y., Bom, M., Rutters, F., Muilwijk, M., Kraft, P., Lindstrom, S., Turman, C., Kiyama, M., Kitamura, A., Yamagishi, K., Gerber, Y., Laatikainen, T., Salonen, J., van Schoor, L., van Zutphen, E., Verschuren, W., Engström, G., Melander, O., Psaty, B., Blaha, M., de Boer, I., Kronmal, R., Sattar, N., Rosengren, A., Nitsch, D., Grandits, G., Tverdal, A., Shin, H.-C., Albertorio, Jr., Gillum, R., Hu, F., Cooper, J., Humphries, S., Hill- Briggs, F., Vrany, E., Butler, M., Schwartz, J., Kiyama, M., Kitamura, A., Iso, H., Amouyel, P., Arveiler, D., Ferrieres, J., Gansevoort, R., de Boer, R., Kieneker, L., Crespo, C., Assmann, G., Trompet, S., Kearney, P., Cantin, B., Després, J., Lamarche, B., Laughlin, G., McEvoy, L., Aspelund, T., Thorsson, B., Sigurdsson, G., Tilly, M., Ikram, M., Dorr, M., Schipf, S., Völzke, H., Fretts, A., Umans, J., Ali, T., Shara, N., Davey-Smith, G., Can, G., Yüksel, H., Özkan, U., Nakagawa, H., Morikawa, Y., Ishizaki, M., Njølstad, I., Wilsgaard, T., Mathiesen, E., Sundström, J., Buring, J., Cook, N., Arndt, V, Rothenbacher, D., Manson, J., Tinker, L., Shipley, M., Tabak, A., Kivimaki, M., Packard, C., Robertson, M., Feskens, E., Geleijnse, M., & Kromhout, D.
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 11
- Issue
- 10
- Pages
- 731-742
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W4386594957
- Cited by
- 231
- References
- 13
- FWCI
- 38.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- NIHR Cambridge Biomedical Research Centre (BCDSA\\100005, NIHR203312, 116074, BRC-1215-20014)
- Economic and Social Research Council (ES/T013192/1)
- British Heart Foundation (RG/18/13/33946, CH/12/2/29428)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. https://app.cochat.ai/papers/10.1016/s2213-8587(23)00223-1
- The paper
- Kaptoge, S., Seshasai, S., Sun, L., Walker, M., Bolton, T., Spackman, S., Ataklte, F., Willeit, P., Bell, S., Burgess, S., Pennells, L., Altay, S., Assmann, G., Ben-Shlomo, Y., Best, L., Björkelund, C., Blazer, D., Brenner, H., Brunner, E., . . . Kromhout, D. (2023). Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(23)00223-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.